# A Study to Compare the Safety and Efficacy of a New Eye Drop Formulation With REFRESH PLUS® in Participants Following LASIK Refractive Surgery

> **NCT01886690** · PHASE3 · COMPLETED · sponsor: **Allergan** · enrollment: 148 (actual)

## Conditions studied

- Bilateral LASIK Surgery

## Interventions

- **DRUG:** carboxymethylcellulose sodium based new eye drop formulation
- **DRUG:** carboxymethylcellulose sodium based eye drops

## Key facts

- **NCT ID:** NCT01886690
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08-20
- **Primary completion:** 2014-08-18
- **Final completion:** 2014-08-18
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2019-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01886690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01886690, "A Study to Compare the Safety and Efficacy of a New Eye Drop Formulation With REFRESH PLUS® in Participants Following LASIK Refractive Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01886690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*